✦ LIBER ✦

Super fractionation in glioblastoma multiforme-results of a phase II study

✍ Scribed by Bruce O. Douglas; Ann J. Worth

Publisher: Elsevier Science
Year: 1982
Tongue: English
Weight: 968 KB
Volume: 8
Category: Article
ISSN: 0360-3016
DOI: 10.1016/0360-3016(82)90303-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fractionation study in the treatment of

Fractionation study in the treatment of glioblastoma multiforme

✍ W.J. Simpson; M.E. Platts 📂 Article 📅 1976 🏛 Elsevier Science 🌐 English ⚖ 530 KB

Evaluation of bromodeoxyuridine in gliob

Evaluation of bromodeoxyuridine in glioblastoma multiforme: A A Northern California cancer center phase II study

✍ T.L. Phillips; V.A. Levin; D.K. Ahn; P.H. Gutin; R.L. Davis; C.B. Wilson; M.D. P 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 748 KB

Phase II study of accelerated fractionat

Phase II study of accelerated fractionation radiation therapy with carboplatin followed by vincristine chemotherapy for the treatment of glioblastoma multiforme

✍ V.A. Levin; M.H. Maor; P.F. Thall; W.K.A. Yung; J. Bruner; R. Sawaya; A.P. Kyrit 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 1000 KB

Carboplatin and teniposide concurrent wi

Carboplatin and teniposide concurrent with radiotherapy in patients with glioblastoma multiforme : A Phase II Study

✍ Alba A. Brandes; Alberto Rigon; Paolo Zampieri; Mario Ermani; Carla Carollo; Giu 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 2 views

## BACKGROUND. The outcome after treatment for glioblastoma remains poor

Phase II study of temozolomide without r

Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly population

✍ Carol Alliot 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB 👁 1 views

Phase II study of temozolomide without r

Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations

✍ Olivier-L. Chinot; Maryline Barrie; Elisabeth Frauger; Henry Dufour; Dominique F 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 1 views

## Abstract ## BACKGROUND Currently, the survival of patients age > 70 years with glioblastoma multiforme (GBM) ranges from 4 months to 6 months, although radiotherapy and/or chemotherapy may prolong survival in certain subgroups. Temozolomide is an oral chemotherapeutic agent with efficacy agains